Zimmer Biomet slips as outlook misses consensus
2025-02-06 10:21:16 ET
More on Zimmer Biomet
- Zimmer Biomet: Back On Offense With Strong Cash Flow Outlook
- Zimmer Biomet Non-GAAP EPS of $2.31 beats by $0.02, revenue of $2.02B beats by $10M
- Zimmer Biomet Q4 2024 Earnings Preview
- Seeking Alpha’s Quant Rating on Zimmer Biomet
- Historical earnings data for Zimmer Biomet
Read the full article on Seeking Alpha
For further details see:
Zimmer Biomet slips as outlook misses consensusNASDAQ: FNA
FNA Trading
0.0% G/L:
$13.09 Last:
19,382,860 Volume:
$13.09 Open:



